| Model: | Residual |
| Symbol | Title | Sector | Industry | M.Cap.[M] | Div Yield | Last Close | AvgVol 200d |
| GTBP | GT Biopharma Inc | Healthcare | Biotechnology | 13 | 6.83 | 56536 | |
| MINT | PIMCO Enhanced Short Maturity Active Exchange-Traded Fund | 0 | 100.65 | 1551781 |
| Entry Threshold: | 2.00 | Exit Threshold: | 0.00 | ||
| Max Duration: | 20 | Entry Mode: | Uptick | Reversals: | |
| Regression Per: | 15 | ||||
| Margin Req. 1: | 50.0 | Margin Req. 2: | 50.0 | ||
| Version: | 5 | Model Version: | 2013.1 | Bid-Ask 0.01 / 0.01 | |
| Initial Capital: | 10000.00 | Final Equity: | 33721.70 |
| Total net P/L: | 23721.70 | Total ROI: | 237.22 % |
| CAGR: | 107.95 % | Max. DD: | 55.56 % |
| System Score: | 61.835 | Sharpe Ratio: | 1.700 |
| Start Date: | 2025-01-02 | End Date: | 2026-08-31 |
| Total days: | 606 | ||
| Commissions: | 471.83 | Comm.% P/L | 1.95 % |
| Total Transactions: | 112 | Log. Linearity: | 83.049 % |
| Total | Long |
Short |
GTBP | MINT | |
|---|---|---|---|---|---|
| Total Profit/Loss | 24193.53 | 6428.74 | 17764.78 | 24548.24 | -354.71 |
| Total Profit | 41312.73 | 22780.53 | 18532.19 | 41442.34 | 211.76 |
| Total Loss | 17119.20 | 16351.79 | 767.41 | 16894.10 | 566.47 |
| Profit Factor | 2.41 | 1.39 | 24.15 | 2.45 | 0.37 |
| Trades | 28 | 17 | 11 | 28 | 28 |
| Winning Trades | 19 | 10 | 9 | 19 | 10 |
| Losing Trades | 9 | 7 | 2 | 9 | 18 |
| % Profitable | 67.00 | 58.00 | 81.00 | 67.00 | 35.00 |
| Profit/Loss Per Trade % | 4.52 | 1.44 | 9.45 | 4.59 | -0.06 |
| Profit Per Trade % | 12.57 | 12.76 | 12.34 | 12.61 | 0.14 |
| Loss Per Trade % | 9.38 | 11.37 | 2.68 | 9.28 | 0.17 |
| Days In Trade | 266 | 181 | 85 | 266 | 266 |
| Days In Trade (Avg. Per Trade) | 9.50 | 10.65 | 7.73 | 9.50 | 9.50 |
| % Days In Trade | 43.89 | 29.87 | 14.03 | 43.89 | 43.89 |